- ADAR1 Capital Management…10% Owner$4.8M
- Doogan DeclanDirector$101.8K
- Giordano Christopher…CEO$20.1K
- Staab Thomas R IIChief Financial…$11K
Insider trading activity for Tenax Therapeutics, INC., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.
4 insiders bought on the open market within 30 days.
The 45 most recent Form 4 transactions.
How quickly insiders here report their trades. Section 16 allows two business days from the transaction.
All 27 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
Everyone who has filed a Form 4 for this issuer.
Other issuers in the same industry with insider filings on record.